Nanobiotechnology in Neurodegenerative Diseases

This book focuses on neurodegenerative diseases which have become a major threat to human health. Neurodegenerative diseases are age related disorders and have become increasingly prevalent in the elderly population in recent years. Hence, there is an urgent need to study and develop new strategies and alternative methods for the treatment of neurodegenerative diseases. This book showcases the promises that nanobiotechnology brings in research, diagnosis, and treatment of neurodegenerative diseases. It is very beneficial for varied group of readers including nanotechnologists, biotechnologists, pharmacists, medical professionals, bioengineers, biochemists and researchers working in this field. Nanobiotechnology in Neurodegenerative Diseases include various chapters including neurodegeneration and neurodegenerative diseases, nanotechnology for the rescue of neurodegenerative diseases, promising potential of nanomaterials for diagnosis and therapy of neurodegenerative diseases, nanotechnology mediated nose-to-brain drug delivery, and formulation and characterization of intranasal nanoparticles of antiretroviral drugs.

Auteur
Dr. Mahendra Rai is Senior Professor and UGC-BSR Faculty Fellow at the Department of Biotechnology, Sant Gadge Baba Amravati University at Amravati, Maharashtra, India. He was a Visiting Scientist at the Department of Bioenergetics, University of Geneva, Switzerland and at the Department of Plant Protection of Debrecen University, Debrecen, Hungary. He visited Department of Chemical Biology, University of Campinas, Brazil under Indo-Brazil Research Programme (DST-CNPq collaboration). He was visiting Professor in Nicolaus Copernicus University, Torun, Poland. He was invited by State University of Campinas, Brazil. Moreover, he was also visiting professor in Ostrava, Czech Republic. His area of expertise includes microbial biotechnology and nanobiotechnology. His present research interests are nanobiotechnology in medicine, agriculture and bioethanol production. He has published more than 400 research papers in national and international journals. In addition, he has edited/authored 50 books and 6 patents.

Dr. Alka Yadav, is a Post Doctoral fellow with Prof Mahendra Rai. She has completed her Master's and Doctoral degree in Biotechnology from Sant Gadge Baba Amravati University, Amravati, Maharashtra, India. She has nine years experience in writing reviews, research articles and book chapters. She has published several research and review articles in high impact factor journals. She also has many book chapters to her credit. She has received the award for the most cited article by Elsevier for the article Silver nanoparticles: as a new generation of antimicrobials published in Biotechnology Advances. She has also worked as guest reviewer with publications like Wiley Publications, Elsevier and SAGE Publications. She has a process patent to her credit entitled Processo de obtencao deum filme basedo em compositos de polisasacarideos de prata, filme obtido e uso. Her areas of interest include Plant Biotechnology, Mycology, Nanobiotechnology, Myconanotechnology and Nano-antimicrobials.

Contenu

Neurodegenerative Diseases: The Real Problem and Nanobiotechnological Solutions.- Nanotechnology at the Rescue of Neurodegenerative Diseases: Tools for Early Diagnostic.- The Role of Nanomedicine in treatment for Neurodegenerative disorders.- Nanobiotechnology in Neurodegenerative Diseases.- Application of Mycogenic Nanoparticles against Neurodegenerative diseases.- Nanotechnology-mediated nose to brain drug delivery for neurodegenerative disorders.- Nanobiotechnology in Parkinson's disease.- Selenium nanoparticles as therapeutic agents in Neurodegenerative diseases.- Role of Supermagnetic nanoparticles in Alzheimer,s disease.- Nanomedicines for improved antiretroviral therapy in Neuro-AIDS.- Nanocarrier mediated drug delivery systems for neurodegenerative diseases.- Gold nanoparticles in diagnosis and treatment of Alzheimer's disease.- Nano-Lipidic Carriers as Potential Drug Delivery Vehicles in Alzheimer's Disease.- Curcumin and its nanoformulations as therapeutic for Alzheimer's disease.- Nanopharmaceuticals for the Improved Treatment of Cerebral Stroke.